Royal Bank of Canada’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.94M | Sell |
219,358
-3,492
| -2% | -$66K | ﹤0.01% | 2804 |
|
|
2026
Q1 | $4.85M | Buy |
222,850
+15,888
| +8% | +$308K | ﹤0.01% | 2440 |
|
|
2025
Q4 | $4.45M | Sell |
206,962
-31,478
| -13% | -$663K | ﹤0.01% | 2514 |
|
|
2025
Q3 | $4.59M | Sell |
238,440
-250,236
| -51% | -$4.46M | ﹤0.01% | 2744 |
|
|
2025
Q2 | $8.36M | Sell |
488,676
-54,707
| -10% | -$2.33M | ﹤0.01% | 2158 |
|
|
2025
Q1 | $34.7M | Sell |
543,383
-29,314
| -5% | -$3.09M | 0.01% | 984 |
|
|
2024
Q4 | $69.6M | Sell |
572,697
-13,292
| -2% | -$1.63M | 0.01% | 701 |
|
|
2024
Q3 | $73.2M | Buy |
585,989
+90,449
| +18% | +$12.5M | 0.01% | 656 |
|
|
2024
Q2 | $78.3M | Buy |
495,540
+34,934
| +8% | +$4.49M | 0.02% | 603 |
|
|
2024
Q1 | $59.6M | Sell |
460,606
-353,423
| -43% | -$43.3M | 0.01% | 714 |
|
|
2023
Q4 | $78.5M | Buy |
814,029
+365,234
| +81% | +$35M | 0.02% | 602 |
|
|
2023
Q3 | $54.4M | Buy |
448,795
+16,051
| +4% | +$1.81M | 0.01% | 662 |
|
|
2023
Q2 | $49.6M | Buy |
432,744
+75,504
| +21% | +$9.74M | 0.01% | 705 |
|
|
2023
Q1 | $49.2M | Buy |
357,240
+51,945
| +17% | +$6.74M | 0.01% | 679 |
|
|
2022
Q4 | $39.6M | Buy |
305,295
+211,138
| +224% | +$24.5M | 0.01% | 771 |
|
|
2022
Q3 | $10.4M | Sell |
94,157
-5,087
| -5% | -$513K | ﹤0.01% | 1502 |
|
|
2022
Q2 | $7.44M | Buy |
99,244
+30,517
| +44% | +$2.25M | ﹤0.01% | 1782 |
|
|
2022
Q1 | $5.37M | Sell |
68,727
-4,867
| -7% | -$373K | ﹤0.01% | 2200 |
|
|
2021
Q4 | $6.63M | Sell |
73,594
-8,901
| -11% | -$761K | ﹤0.01% | 2193 |
|
|
2021
Q3 | $7.63M | Sell |
82,495
-101,433
| -55% | -$7.81M | ﹤0.01% | 2012 |
|
|
2021
Q2 | $14.3M | Buy |
183,928
+127,243
| +224% | +$9.65M | ﹤0.01% | 1577 |
|
|
2021
Q1 | $4.22M | Sell |
56,685
-16,572
| -23% | -$1.53M | ﹤0.01% | 2371 |
|
|
2020
Q4 | $12.5M | Sell |
73,257
-44,319
| -38% | -$6.57M | ﹤0.01% | 1553 |
|
|
2020
Q3 | $16.5M | Buy |
117,576
+11,716
| +11% | +$1.78M | 0.01% | 1205 |
|
|
2020
Q2 | $17M | Buy |
105,860
+32,025
| +43% | +$4.36M | 0.01% | 1129 |
|
|
2020
Q1 | $7.22M | Sell |
73,835
-24,221
| -25% | -$2.77M | ﹤0.01% | 1558 |
|
|
2019
Q4 | $12.7M | Buy |
98,056
+16,563
| +20% | +$1.67M | ﹤0.01% | 1459 |
|
|
2019
Q3 | $6.14M | Buy |
81,493
+4,874
| +6% | +$576K | ﹤0.01% | 1930 |
|
|
2019
Q2 | $11.6M | Sell |
76,619
-341
| -0.4% | -$41.4K | ﹤0.01% | 1449 |
|
|
2019
Q1 | $9.17M | Sell |
76,960
-46,918
| -38% | -$6.03M | ﹤0.01% | 1576 |
|
|
2018
Q4 | $13.5M | Sell |
123,878
-26,565
| -18% | -$3.32M | 0.01% | 1259 |
|
|
2018
Q3 | $24.3M | Sell |
150,443
-7,385
| -5% | -$1.01M | 0.01% | 998 |
|
|
2018
Q2 | $20.9M | Sell |
157,828
-131,066
| -45% | -$12.4M | 0.01% | 1046 |
|
|
2018
Q1 | $21.4M | Sell |
288,894
-6,428
| -2% | -$429K | 0.01% | 1052 |
|
|
2017
Q4 | $16.4M | Buy |
295,322
+209,373
| +244% | +$11.1M | 0.01% | 1262 |
|
|
2017
Q3 | $3.9M | Buy |
85,949
+72,897
| +559% | +$2.91M | ﹤0.01% | 2170 |
|
|
2017
Q2 | $440K | Sell |
13,052
-5,104
| -28% | -$166K | ﹤0.01% | 3750 |
|
|
2017
Q1 | $538K | Buy |
18,156
+12,009
| +195% | +$372K | ﹤0.01% | 3582 |
|
|
2016
Q4 | $168K | Buy |
6,147
+3,256
| +113% | +$131K | ﹤0.01% | 4590 |
|
|
2016
Q3 | $177K | Sell |
2,891
-1,115
| -28% | -$33.7K | ﹤0.01% | 4511 |
|
|
2016
Q2 | $76K | Buy |
4,006
+405
| +11% | +$7.5K | ﹤0.01% | 4902 |
|
|
2016
Q1 | $71K | Sell |
3,601
-3,428
| -49% | -$59.9K | ﹤0.01% | 4943 |
|
|
2015
Q4 | $271K | Buy |
7,029
+152
| +2% | +$4.93K | ﹤0.01% | 4307 |
|
|
2015
Q3 | $221K | Buy |
6,877
+2,587
| +60% | +$87.8K | ﹤0.01% | 4240 |
|
|
2015
Q2 | $131K | Sell |
4,290
-135
| -3% | -$2.76K | ﹤0.01% | 4670 |
|
|
2015
Q1 | $58K | Sell |
4,425
-395
| -8% | -$5.26K | ﹤0.01% | 4900 |
|
|
2014
Q4 | $70K | Buy |
4,820
+2,494
| +107% | +$42.2K | ﹤0.01% | 4901 |
|
|
2014
Q3 | $48K | Sell |
2,326
-20
| -0.9% | -$451 | ﹤0.01% | 4971 |
|
|
2014
Q2 | $70K | Buy |
2,346
+60
| +3% | +$1.9K | ﹤0.01% | 4699 |
|
|
2014
Q1 | $55K | Hold |
2,286
| – | – | ﹤0.01% | 4822 |
|
|
2013
Q4 | $46K | Sell |
2,286
-233
| -9% | -$6.92K | ﹤0.01% | 4929 |
|
|
2013
Q3 | $119K | Buy |
2,519
+20
| +0.8% | +$770 | ﹤0.01% | 4374 |
|
|
2013
Q2 | $95K | Buy |
+2,499
| New | +$89.4K | ﹤0.01% | 4334 |
|
Other funds holding SRPT
EAM
Royal Bank of Canada's SRPT Position: Q2 2026 in Review
Royal Bank of Canada reduced its Sarepta Therapeutics (SRPT) stake by 1.6% in Q2 2026, selling an estimated $66K and leaving 219,358 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.
Royal Bank of Canada first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.5M in Q4 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Royal Bank of Canada held 219,358 shares of Sarepta Therapeutics worth $3.94M as of Q2 2026.
- Royal Bank of Canada sold 3,492 Sarepta Therapeutics shares in Q2 2026, an estimated $66K.
- Sarepta Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2804 holding.
- Royal Bank of Canada first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Sarepta Therapeutics position peaked at $78.5M in Q4 2023.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.